Money Life With Chuck Jaffe Daily Podcast

Lydon: Clinical trials ETF creates a unique opportunity for biotech investors.

Informações:

Sinopse

Tom Lydon of ETFTrends.com made the Virtus LifeSciences Biotech Clinical Trials ETF his 'ETF of the Week,' noting that the fund gives investors a unique way to play the cutting edge in small and mid-sized pharma companies, The index the fnud is based on cuts out big pharma names and drills down to companies with lead drug candidates in trial phases. Also, author Robin Ryan discusses reinventing retirement, Chuck takes an audience question about his best investment ever, and the Market Call is a rebroadcast